ARCHIVES

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

Cancer Biomarker Research “Piecemeal and Unorganized,” IOM Report Finds.

April 6, 2007

Rep. Regula To Lead House Labor, HHS; Specter Likely Senate Labor, HHS Chairman.

January 12, 2001

Rep. Bliley Challenges FDA On Failure To Approve Oral Colon Cancer Drug UFT.

April 21, 2000

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

April 3, 1992

Oral UFT Equivalent To FULV In Stage II and III Colon Cancer

July 30, 2004

In Congress: Mack Urges Stevens To Add $2 Billion To NIH Appropriations

June 13, 1997